Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Erythema nodosum linked to kerion can be treated effectively with antifungals and steroids to reduce scarring.

Euphorbia hirta oil may promote hair growth naturally.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Multitarget drugs are needed to better treat complex diseases.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

New treatments for severe alopecia areata show promise but lack standard approval.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Using electronic health records can help identify drug side effects but has some limitations.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Rare earth elements are crucial in medical imaging and cancer treatment.